BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32793240)

  • 1. Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota.
    Kaneko K; Akagawa S; Akagawa Y; Kimata T; Tsuji S
    Front Immunol; 2020; 11():1616. PubMed ID: 32793240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease.
    Wang F; Qian F; Zhang Q; Zhao J; Cen J; Zhang J; Zhou J; Luo M; Jia C; Rong X; Chu M
    Front Immunol; 2023; 14():1124118. PubMed ID: 37398673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease.
    Teramoto Y; Akagawa S; Hori SI; Tsuji S; Higasa K; Kaneko K
    Front Immunol; 2023; 14():1268453. PubMed ID: 38022552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
    Saresella M; Marventano I; Barone M; La Rosa F; Piancone F; Mendozzi L; d'Arma A; Rossi V; Pugnetti L; Roda G; Casagni E; Cas MD; Paroni R; Brigidi P; Turroni S; Clerici M
    Front Immunol; 2020; 11():1390. PubMed ID: 32733460
    [No Abstract]   [Full Text] [Related]  

  • 6. Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells.
    Alrafas HR; Busbee PB; Nagarkatti M; Nagarkatti PS
    J Leukoc Biol; 2019 Aug; 106(2):467-480. PubMed ID: 30897248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis.
    Zhu L; Xu LZ; Zhao S; Shen ZF; Shen H; Zhan LB
    Appl Microbiol Biotechnol; 2020 Jun; 104(12):5449-5460. PubMed ID: 32322944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis of gut microbiota induced the disorder of helper T cells in influenza virus-infected mice.
    Yu B; Dai CQ; Chen J; Deng L; Wu XL; Wu S; Zhao CL; Jiang ZY; Chen XY
    Hum Vaccin Immunother; 2015; 11(5):1140-6. PubMed ID: 25874358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis.
    Chen P; Tang X
    Front Immunol; 2021; 12():803101. PubMed ID: 35003133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
    de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
    Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gut microbiota in idiopathic nephrotic syndrome in children.
    Kaneko K; Tsuji S; Kimata T
    Med Hypotheses; 2017 Oct; 108():35-37. PubMed ID: 29055396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid.
    Su X; Yin X; Liu Y; Yan X; Zhang S; Wang X; Lin Z; Zhou X; Gao J; Wang Z; Zhang Q
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the oral and gut microbiota in patients with Kawasaki disease.
    Zeng Q; Zeng R; Ye J
    PeerJ; 2023; 11():e15662. PubMed ID: 37456866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
    Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
    Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes.
    Tan C; Wu Q; Wang H; Gao X; Xu R; Cui Z; Zhu J; Zeng X; Zhou H; He Y; Yin J
    JPEN J Parenter Enteral Nutr; 2021 Mar; 45(3):518-529. PubMed ID: 32473086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis.
    Meisel M; Mayassi T; Fehlner-Peach H; Koval JC; O'Brien SL; Hinterleitner R; Lesko K; Kim S; Bouziat R; Chen L; Weber CR; Mazmanian SK; Jabri B; Antonopoulos DA
    ISME J; 2017 Jan; 11(1):15-30. PubMed ID: 27648810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota Dysbiosis in Children with Relapsing Idiopathic Nephrotic Syndrome.
    Tsuji S; Suruda C; Hashiyada M; Kimata T; Yamanouchi S; Kitao T; Kino J; Akane A; Kaneko K
    Am J Nephrol; 2018; 47(3):164-170. PubMed ID: 29533950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long and winding road to the etiology of idiopathic nephrotic syndrome in children: Focusing on abnormalities in the gut microbiota.
    Tsuji S; Kaneko K
    Pediatr Int; 2021 Sep; 63(9):1011-1019. PubMed ID: 33657643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
    Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
    Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.